These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7687858)

  • 1. Further investigations on the expression of HLA-DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34+ haematopoietic progenitor cells.
    Pierelli L; Teofili L; Menichella G; Rumi C; Paoloni A; Iovino S; Puggioni PL; Leone G; Bizzi B
    Br J Haematol; 1993 May; 84(1):24-30. PubMed ID: 7687858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominance of myeloid antigens in CD34-positive peripheral blood stem cells over those in bone marrow after administration of granulocyte colony-stimulating factor.
    Fukuda T; Okamura S; Shimoda K; Takamatsu Y; Inaba S; Harada M; Niho Y
    Eur J Haematol; 1994 Apr; 52(4):201-6. PubMed ID: 7516293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.
    Verfaillie CM; Miller JS
    Blood; 1994 Sep; 84(5):1442-9. PubMed ID: 7520771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative responses to interleukin-3 and granulocyte colony-stimulating factor distinguish a minor subpopulation of CD34-positive marrow progenitors that do not express CD33 and a novel antigen, 7B9.
    Litzow MR; Brashem-Stein C; Andrews RG; Bernstein ID
    Blood; 1991 Jun; 77(11):2354-9. PubMed ID: 1710150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD33, CD38, and HLA-DR on CD34+ human fetal liver progenitors with a high proliferative potential.
    Muench MO; Cupp J; Polakoff J; Roncarolo MG
    Blood; 1994 Jun; 83(11):3170-81. PubMed ID: 7514903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic analysis and characterization of CD34+ cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation.
    Bender JG; Unverzagt K; Walker DE; Lee W; Smith S; Williams S; Van Epps DE
    Clin Immunol Immunopathol; 1994 Jan; 70(1):10-8. PubMed ID: 7505211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional differences between CD38- and DR- subfractions of CD34+ bone marrow cells.
    Rusten LS; Jacobsen SE; Kaalhus O; Veiby OP; Funderud S; Smeland EB
    Blood; 1994 Sep; 84(5):1473-81. PubMed ID: 7520773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens.
    Sakabe H; Ohmizono Y; Tanimukai S; Kimura T; Mori KJ; Abe T; Sonoda Y
    Stem Cells; 1997; 15(1):73-81. PubMed ID: 9007225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of CD34+ subsets and clonogenicity in human bone marrow, granulocyte colony-stimulating factor-mobilized peripheral blood, and cord blood.
    Cho SH; Chung IJ; Lee JJ; Park ML; Kim HJ
    J Korean Med Sci; 1999 Oct; 14(5):520-5. PubMed ID: 10576147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhG-CSF-mobilized CD34+ peripheral blood progenitors are myeloperoxidase-negative and noncycling irrespective of CD33 or CD13 coexpression.
    Rumi C; Rutella S; Teofili L; Etuk B; Ortu La Barbera E; Micciulli G; Voso MT; Leone G
    Exp Hematol; 1997 Mar; 25(3):246-51. PubMed ID: 9091301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
    Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
    Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric characterization of CD34+ hematopoietic progenitor cells in mobilized peripheral blood and bone marrow of cancer patients.
    D'Arena G; Cascavilla N; Musto P; Greco M; Di Mauro L; Carella AM; Dello Iacono N; Carotenuto M
    Haematologica; 1996; 81(3):216-23. PubMed ID: 8767526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the coexpression of CD38, CD33 and HLA-DR antigens on CD34+ purified cells from human cord blood and bone marrow.
    De Bruyn C; Delforge A; Bron D; Bernier M; Massy M; Ley P; de Hemptinne D; Stryckmans P
    Stem Cells; 1995 May; 13(3):281-8. PubMed ID: 7613494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential expression of CD34 and CD33 antigens on myeloid colony-forming cells.
    Bühring HJ; Asenbauer B; Katrilaka K; Hummel G; Busch FW
    Eur J Haematol; 1989 Feb; 42(2):143-9. PubMed ID: 2465178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of adhesion molecules and c-kit on CD34+ hematopoietic progenitor cells: comparison of cytokine-mobilized blood stem cells with normal bone marrow and peripheral blood.
    Möhle R; Haas R; Hunstein W
    J Hematother; 1993; 2(4):483-9. PubMed ID: 7522108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of peripheral blood CD34+ progenitor cells mobilized with chemotherapy and granulocyte colony-stimulating factor.
    Teofili L; Iovino MS; Sica S; Pierelli L; Menichella G; De Stefano V; Rumi C; Leone G
    Exp Hematol; 1994 Sep; 22(10):990-5. PubMed ID: 7522187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells.
    Gaipa G; Coustan-Smith E; Todisco E; Maglia O; Biondi A; Campana D
    Haematologica; 2002 Apr; 87(4):347-56. PubMed ID: 11940478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor.
    Siena S; Bregni M; Brando B; Ravagnani F; Bonadonna G; Gianni AM
    Blood; 1989 Nov; 74(6):1905-14. PubMed ID: 2478216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.